Agenus’ vaccine for a deadly form of brain cancer helped extend patients’ lives in a single-arm study, the company said, news that sent its shares up as much as 20% on hopes it can find a partner to help it into Phase III.

…read more

Source: Agenus spikes on positive data for its brain cancer vaccine


0 No comments